Literature DB >> 18143590

A labile component of normal serum which combines with various viruses; neutralization of infectivity and inhibition of hemagglutination by the component.

H S GINSBERG, F L HORSFALL.   

Abstract

A labile component present in the serum of human beings, guinea pigs, and rabbits neutralizes the infectivity of mumps, Newcastle disease, influenza A and B viruses. The labile component of these sera and of mouse serum also inhibits hemagglutination of chicken RBC by these viruses. The component is inactivated by heating at 56 degrees C. for 30 minutes and upon storage at 4 degrees C. for periods longer than 2 weeks. The virus-neutralizing and hemagglutination-inhibiting properties result from serum component-virus combination in the presence of calcium. The combination is stable, and does not undergo spontaneous dissociation. Partial separation of virus can be brought about by heating mixtures held for 24 hours or by removal of calcium ions with sodium citrate. The labile serum component appears to be distinct from hemolytic complement.

Entities:  

Keywords:  BLOOD/colloids; VIRUSES

Mesh:

Substances:

Year:  1949        PMID: 18143590      PMCID: PMC2135926          DOI: 10.1084/jem.90.5.475

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  8 in total

1.  Experience with Vaccination Against Influenza in the Spring of 1947: A Preliminary Report.

Authors:  T Francis; J E Salk; J J Quilligan
Journal:  Am J Public Health Nations Health       Date:  1947-08

2.  Reactions between influenza virus and a component of allantoic fluid.

Authors:  P H HARDY; F L HORSFALL
Journal:  J Exp Med       Date:  1948-10-01       Impact factor: 14.307

3.  STUDIES ON A NON-HEMOLYTIC STREPTOCOCCUS ISOLATED FROM THE RESPIRATORY TRACT OF HUMAN BEINGS : II. IMMUNOLOGICAL CHARACTERISTICS OF STREPTOCOCCUS MG.

Authors:  G S Mirick; L Thomas; E C Curnen; F L Horsfall
Journal:  J Exp Med       Date:  1944-11-01       Impact factor: 14.307

4.  The inhibitory effect of polysaccharide on mumps virus multiplication.

Authors:  H S GINSBERG; W F GOEBEL; F L HORSFALL
Journal:  J Exp Med       Date:  1948-05-01       Impact factor: 14.307

5.  THE QUANTITATIVE DETERMINATION OF INFLUENZA VIRUS AND ANTIBODIES BY MEANS OF RED CELL AGGLUTINATION.

Authors:  G K Hirst
Journal:  J Exp Med       Date:  1942-01-01       Impact factor: 14.307

6.  The associative reactions of pneumonia virus of mice and influenza viruses; the effects of pH and electrolytes upon virus-host cell combinations.

Authors:  F M DAVENPORT; F L HORSFALL
Journal:  J Exp Med       Date:  1948-12       Impact factor: 14.307

7.  THE ACTIVATING EFFECT OF MAGNESIUM AND OTHER CATIONS ON THE HEMOLYTIC FUNCTION OF COMPLEMENT.

Authors:  M M Mayer; A G Osler; O G Bier; M Heidelberger
Journal:  J Exp Med       Date:  1946-11-30       Impact factor: 14.307

8.  DISSOCIATION OF HEMAGGLUTINATING AND ANTIBODY-MEASURING CAPACITIES OF INFLUENZA VIRUS.

Authors:  T Francis
Journal:  J Exp Med       Date:  1947-01-01       Impact factor: 14.307

  8 in total
  13 in total

1.  Comparison of the experimental results obtained in the course of inactivation of non-specific inhibitors in serum by means of the haemagglutination inhibition and virus neutralization tests.

Authors:  S HORVATH
Journal:  Arch Gesamte Virusforsch       Date:  1961

2.  [Nonspecific inhibitory factors against influenza viruses in the normal serum of guinea pigs].

Authors:  H LIPPELT; W WIRTH
Journal:  Arch Gesamte Virusforsch       Date:  1959

3.  [On Newcastle infection in man].

Authors:  R SIEGERT; H G HAUSSMANN; E MANNWEILER
Journal:  Klin Wochenschr       Date:  1954-01-01

Review 4.  Virulence of influenza A virus for mouse lung.

Authors:  A C Ward
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

5.  Effect of various methods of removing non-specific inhibitors to virus hemagglutination upon serum proteins and immunoglobulins.

Authors:  N M Tauraso; F A Pedreira; S L Spector; G M Bernier
Journal:  Arch Gesamte Virusforsch       Date:  1971

6.  Inhibitors against rabies virus present in normal rabbit sera.

Authors:  N Sekine; K Yoshino
Journal:  Arch Gesamte Virusforsch       Date:  1974

7.  Biological functions of monospecific antibodies to envelope glycoproteins of Newcastle disease virus.

Authors:  Y Umino; T Kohama; M Kohase; A Sugiura; H D Klenk; R Rott
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

8.  The properdin system and immunity. V. The bactericidal activity of the properdin system.

Authors:  A C WARDLAW; L PILLEMER
Journal:  J Exp Med       Date:  1956-05-01       Impact factor: 14.307

9.  The properdin system and immunity. VI. The inactivation of Newcastle disease virus by the properdin system.

Authors:  H S GINSBERG; L PILLEMER; R J WEDGWOOD
Journal:  J Exp Med       Date:  1956-11-01       Impact factor: 14.307

10.  Immunological reactions of the Coxsackie viruses. I. The neutralization test; technic and application.

Authors:  J L MELNICK; N LEDINKO
Journal:  J Exp Med       Date:  1950-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.